NCT02153099View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of ENV8058 (TAK-058) in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Dose Finding Study
Interventions
DRUG

TAK-058 (ENV8058)

TAK-058 (ENV8058) oral solution

DRUG

Placebo

TAK-058 (ENV8058) placebo-matching oral solution

Trial Locations (1)

Unknown

Austin

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY